Table 3 Prevlance of chronic vascular complications among adult clinically-registered people with diabetes in Iran.

Women

≤44

2,729 (9.0%)

10.10%

11.00%

16.70%

8.20%

2.70%

18.70%

6.40%

2.10%

32.30%

8.97–11.23

9.83–12.17

15.3–18.1

7.17–9.23

2.09–3.31

17.24–20.16

5.48–7.32

1.56–2.64

30.55–34.05

45 to 64

12,952 (42.9%)

22.30%

16.50%

30.30%

22.60%

5.30%

30.60%

13.10%

4.10%

57.50%

21.58–23.02

15.86–17.14

29.51–31.09

21.88–23.32

4.91–5.69

29.81–31.39

12.52–13.68

3.76–4.44

56.65–58.35

≥65

4,417 (14.6%)

27.70%

20.50%

33.80%

34.40%

6.30%

33.30%

15.60%

5.80%

66.90%

26.38–29.02

19.31–21.69

32.40–35.20

33.00–35.80

5.85–7.02

13.91–34.69

14.53–16.67

5.11–6.49

65.51–68.29

Total

20,098 (66.5%)

21.80%

16.70%

29.20%

23.20%

5.20%

29.60%

12.70%

4.20%

56.20%

21.23–22.37

16.18–17.22

28.57–29.83

22.62–23.78

4.89–5.51

28.97–30.23

12.24–13.16

3.92–4.48

55.51–56.89

Men

≤44

1,248 (4.1%)

10.80%

16.00%

17.20%

8.00%

5.40%

22.90%

7.00%

2.40%

38.00%

9.08–12.52

13.97–18.03

15.11–19.29

6.49–9.51

4.15–6.65

20.57–25.23

5.58–8.42

1.55–3.25

35.31–40.69

45 to 64

5,740 (19.0%)

22.30%

18.10%

25.20%

23.50%

8.40%

28.10%

12.40%

4.20%

55.80%

21.22–23.38

17.10–19.10

24.08–26.32

22.40–24.60

7.68–9.12

26.94–29.26

11.55–13.25

3.68–4.72

54.52–57.08

≥65

3,116 (10.3%)

25.60%

23.00%

29.90%

34.80%

9.30%

28.90%

15.70%

6.10%

65.60%

24.07–27.13

21.52–24.48

28.29–31.51

33.13–36.47

8.28–10.32

27.31–30.49

14.42–16.98

5.26–6.94

63.69–67.27

Total

10,104 (33.5%)

21.90%

19.40%

25.70%

25.10%

8.30%

27.70%

12.70%

4.60%

56.60%

21.09–22.71

18.63–20.17

24.85–26.55

24.25–25.95

7.76–8.84

26.83–28.57

12.05–13.35

4.19–5.01

55,63–57.57

Total

30,202 (100%)

21.90%

17.60%

28.00%

23.90%

6.20%

29.00%

12.70%

4.30%

55.70%

21.43–22.37

17.17–18.03

27.49–28.51

23.42–24.38

5.93–6.47

28.49–29.51

12.32–13.08

4.07–4.53

55.14–56.26